Your browser doesn't support javascript.
loading
Malignant hypertension presenting as hemolysis, thrombocytopenia, and renal failure.
Khanna, Avinash; McCullough, Peter A.
Afiliação
  • Khanna A; Department of Medicine, Cardiology Section, University of Missouri at Kansas City School of Medicine, Truman Medical Center, Kansas City, Missouri, USA.
Rev Cardiovasc Med ; 4(4): 255-9, 2003.
Article em En | MEDLINE | ID: mdl-14674379
This case review describes a patient presenting to the emergency department with malignant hypertension, a medical emergency occurring in up to 1% of the hypertensive population. The features of malignant hypertension resemble those of other diseases. For example, the association between red-cell fragmentation and malignant hypertension is thought to be due to endothelial injury and fibrinoid necrosis, which promote hemolysis, platelet destruction, and varying degrees of renal failure, resulting in a clinical picture similar to that of thrombotic thrombocytopenic purpura. Resolving the hemolysis and improving the renal function can only be achieved through rapid and effective control of the blood pressure. Without treatment, the survival rate for malignant hypertension is 10% to 35%. With appropriate treatment, the 5-year survival rate is 75%.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Injúria Renal Aguda / Hemólise / Hipertensão Maligna / Anti-Hipertensivos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Adult / Humans / Male Idioma: En Revista: Rev Cardiovasc Med Ano de publicação: 2003 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Injúria Renal Aguda / Hemólise / Hipertensão Maligna / Anti-Hipertensivos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Adult / Humans / Male Idioma: En Revista: Rev Cardiovasc Med Ano de publicação: 2003 Tipo de documento: Article